Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.17%
#3 Velvet Velvet +37.34%
#4 Black Phoenix Black Phoenix +34.06%
#5 Akedo Akedo +29.10%
#6 Cross Cross +27.01%
#7 Cap Cap +18.79%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.46%
#9 QANplatform QANplatform +14.35%
#10 Bitway Bitway +13.02%
Coin of the day
Glidr Glidr
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
AIM ImmunoTech Inc. AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

AIM
Hisse Senetlerindeki Sıralama #38741
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida,... AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company, originally incorporated in 1966, was formerly known as Hemispherx Biopharma, Inc. until its name change in August 2019.
Hisse Fiyatı
$0.2442
Piyasa Değeri
$831.14K
Değişim (1 gün)
-5.46%
Değişim (1 yıl)
-89.91%
Ülke
US
Ticaret AIM ImmunoTech Inc. (AIM)

Kategori

Healthcare
AIM ImmunoTech Inc. (AIM) için kazanç
2026 itibarıyla kazanç TTM: 0
AIM ImmunoTech Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
AIM ImmunoTech Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE